Evaluation of Analytical Process Performance of Urine Creatinine Using Different Quality Assessment Models in a Toxicology Laboratory
Journal of Turkish Clinical Biochemistry · 06.11.2026
DOI: 10.65717/jtcb.2026.26038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Turkish Clinical Biochemistry, online erschienen am 06.11.2026. Verfasst von Mehmet Akif Bozdayi und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aimed to evaluate the analytical process performance of the urine creatinine test, which is routinely used within urine specimen validity testing, by applying measurement uncertainty (MU), total analytical error (TAE), and sigma metric performance assessment models. In addition, the authors investigated the impact of MU on decision limits used for dilution assessment.
Methods
External quality assessment and internal quality control data for urine creatinine testing were obtained retrospectively. Expanded MU, TAE, and sigma metrics were subsequently calculated.
Results
The expanded MU calculated according to the Nordtest approach was 17.70%. Based on this uncertainty, the adjusted upper decision limit for dilution was determined as 20 ± 3.5 mg/dL, and the lower decision limit as 4.5 ± 0.8 mg/dL. Overall, 1.5% of the reported urine creatinine results fell within the uncertainty-adjusted decision limit ranges. Total analytical error was calculated as 17.26% for the low level and 13.84% for the high level. Sigma metric values showed substantial variation depending on the selected allowable total error specification.
Conclusion
Continuous monitoring of analytical performance indicators for urine creatinine can assist laboratory professionals in evaluating and improving result reliability. Moreover, awareness of these performance characteristics by individuals interpreting test results may further enhance confidence in reported values. The findings of this study highlight the importance of incorporating laboratory-specific MU into the interpretation of urine creatinine results near dilution decision limits. The authors also suggest that defining analytical performance targets for laboratory tests in relevant guidelines would be beneficial for the standardization of result quality.
Zitieren
APA
Bozdayi, M. A., Bozdayi, İ. G., & Çakırca, G. (2026). Evaluation of Analytical Process Performance of Urine Creatinine Using Different Quality Assessment Models in a Toxicology Laboratory. Journal of Turkish Clinical Biochemistry. https://doi.org/10.65717/jtcb.2026.26038
Vancouver
Bozdayi MA, Bozdayi İG, Çakırca G. Evaluation of Analytical Process Performance of Urine Creatinine Using Different Quality Assessment Models in a Toxicology Laboratory. Journal of Turkish Clinical Biochemistry. 2026. doi:10.65717/jtcb.2026.26038
BibTeX
@article{Bozdayi2026,
author = {Bozdayi, Mehmet Akif and Bozdayi, İsmet Gamze and Çakırca, Gökhan},
title = {Evaluation of Analytical Process Performance of Urine Creatinine Using Different Quality Assessment Models in a Toxicology Laboratory},
journal = {Journal of Turkish Clinical Biochemistry},
year = {2026},
doi = {10.65717/jtcb.2026.26038}
}
EUVIMED